Perspective Therapeutics, Inc. — Director's Dealing 2022

Sep 22, 2022

SEC Form 4/A — Form 4/A

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-08-18

Reporting Person: Streeter Jennifer (COO & VP of HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-18	Common Stock	M	50000	$0.43	Acquired	77940	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-18	Stock Options (right to buy)	$0.43	M	50000	Disposed	2029-06-18	Common Stock (100000)	Direct

Footnotes

F1: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022.

F2: The previous Form 4 incorrectly stated 87,940 shares owned, but should have stated 77,940 shares owned.